Search - tctmd.com

Displaying 101 - 120 of 313

Sort: Relevancy | Date

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Daily News

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

L.A. McKeown

September 09, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

L.A. McKeown

August 10, 2015

News Daily News

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Yael L. Maxwell

August 07, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Featured Fellow

Kimberly Atianzar, MD

Yael L. Maxwell

July 20, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

Advertisement

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Registry Charts Trends in Mechanical Circulatory Support During PCI

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Kimberly Atianzar, MD

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content